Capital Advisor Network’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Capital Advisor Network's NBIX Position: Q3 2026 in Review
Capital Advisor Network opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 2 shares worth $284. The stake represents ﹤0.01% of the portfolio and ranks #236 among its holdings.
760 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Capital Advisor Network held 2 shares of Neurocrine Biosciences worth $284 as of Q3 2026.
- Neurocrine Biosciences was a new Capital Advisor Network position in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of Capital Advisor Network's portfolio in Q3 2026, its #236 holding.
- 760 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Capital Advisor Network's 13F filing for Q3 2026, filed 13 Nov 2026.